Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

NACompletedINTERVENTIONAL
Enrollment

906

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2019

Study Completion Date

August 31, 2020

Conditions
GlaucomaGlaucoma SuspectDiabetic RetinopathyOcular HypertensionCataractBranch Retinal Vein OcclusionBranch Retinal Arterial OcclusionCentral Retinal Vein OcclusionCentral Retinal Artery OcclusionEpi-retinal MembraneMacular DegenerationDrusenLoss of Vision
Interventions
OTHER

Free Eye Screenings

This group will receive free eye screening and follow-up comprehensive ophthalmic exam if recommended.

OTHER

Enhanced Intervention

This group will receive ophthalmic referral and a navigator for assistance in scheduling appointments; confirming appointments via phone, mail, email and/or text message; arranging transportation through Customized Community Transportation (CCT) and Philadelphia Paratransit Service; and trained medical interpreters as needed.

OTHER

Usual Care

This group will receive ophthalmic referral.

Trial Locations (1)

19107

Wills Eye Glaucoma Service, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Westat

OTHER

collaborator

Public Health Management Corporation

OTHER

collaborator

Philadelphia Department of Public Health

OTHER_GOV

collaborator

Health Federation of Philadelphia

OTHER

collaborator

Temple Physicians, Inc.

INDUSTRY

lead

Wills Eye

OTHER